Clinical Trial Update: Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94 [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating intra-articular administration of tgAAC94 in rheumatoid arthritis; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• tgAAC94

Snippet

Sponsor: Targeted Genetics Corporation | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED